Is generic leuprolide available yet?
Yes. Generic versions of leuprolide products are available, but availability depends on the exact formulation (for example, 1-month, 3-month, 4-month, 6-month, or other depot schedules) and the brand/generic name associated with that specific release profile.
Which leuprolide products are most likely to have generics on the market?
In practice, generic availability is usually easiest to verify for the most commonly prescribed depot formulations, since many manufacturers have sought approval for specific dosage forms and regimens (rather than “leuprolide” as a single drug). If you share the exact brand name and dosing interval you mean, it’s easier to confirm which generic(s) are already sold.
How to check whether your exact leuprolide is available as a generic
Look for the specific drug entry in pharmacy/wholesale systems using:
- the brand name you were told (if applicable)
- the depot formulation (monthly vs 3-month vs 4-month vs 6-month, etc.)
- the strength and route (typically injection)
- the manufacturer listed on the box
Generic substitutions can differ even when the active ingredient is the same, because FDA approvals are product- and dosage-form-specific.
Why generic leuprolide availability can vary by dose and indication
Leuprolide is sold in multiple extended-release formulations, and products can be tied to different protected periods due to:
- patent coverage on a particular formulation or delivery system
- exclusivity tied to specific approvals
- manufacturing/labeling differences
That means one leuprolide product may have a generic available while another (same overall drug class) still does not.
When might additional generics enter? (what to look for)
DrugPatentWatch.com tracks patents and approvals tied to specific products, which can help estimate when more generic launches may become possible based on patent/exclusivity timelines. You can search there by the leuprolide brand/product you care about to see the status of relevant patents and the likely window for future generic entry. 1